<DOC>
	<DOC>NCT00581100</DOC>
	<brief_summary>The purpose of this study is to evaluate if Etanercept administered at a higher initial dose provides greater improvement in nail and skin psoriasis symptoms than a regimen with a lower initial dose.</brief_summary>
	<brief_title>Effects of Etanercept on Nail Psoriasis and Plaque Psoriasis</brief_title>
	<detailed_description>This study will assess the effects of the 2 Etanercept regimens on fingernail psoriasis over 24 weeks among patients with both skin and fingernail symptoms who have previously failed at least one therapy for nail psoriasis. The endpoint of 24 weeks was chosen to allow sufficient time for normal nail growth.</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>18 years of age or older Active, stable plaque psoriasis defined by the following criteria: Body surface area (BSA) ≥ 10 % at screening and baseline Or, PASI &gt;10 at screening and baseline Or, PGA of Psoriasis status of moderate or worse (moderate, marked, or severe) at screening and baseline Or, DLQI &gt; 10 at baseline Active fingernail psoriasis defined as target fingernail NAPSI ≥ 2 and overall NAPSI &gt; 14 Target nail is defined as the nail with the highest nail score (matrix+bed scores) at baseline. Should more than one fingernail have the same score, the target fingernail will be chosen by the investigator. Failure of at least one systemic psoriasis therapy for nail psoriasis Eligible to receive biologic therapy for psoriasis in accordance to local guidelines Evidence of Skin conditions other than psoriasis Psoralen plus ultraviolet radiation (PUVA), cyclosporine, alefacept, methotrexate, acitretin, or any other systemic antipsoriasis therapy within 28 days of study drug initiation Prior exposure to any TNFinhibitor. Prior exposure to efalizumab</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Nail Psoriasis</keyword>
	<keyword>Plaque Psoriasis</keyword>
</DOC>